Physician profile
Sunitha Abraham
NPI 1538668413
$2,058.49
in general payments reported to CMS, 2019-2025
11 companies · $682 in 2025
The $682 reported for 2025 was more than what 82% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.19 · 2023: $483 · 2024: $866 · 2025: $682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,547 · Travel and Lodging: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,547.34 |
| Travel and Lodging | $482.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $482.96 | 2023 | Da Vinci Surgical System |
| Otsuka America Pharmaceutical, INC. | $349.24 | 2024-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $303.47 | 2024-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $268.59 | 2024-2025 | Fanapt |
| Axsome Therapeutics, INC. | $205.49 | 2024-2025 | Auvelity |
| Neurocrine Biosciences, INC. | $138.51 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $121.96 | 2024 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $121.40 | 2024 | Austedo Xr |
| Siemens Medical Solutions USA, INC. | $28.19 | 2021 | |
| Lundbeck LLC | $20.52 | 2025 | Abilify Asimtufii |
| Boston Scientific Corporation | $18.16 | 2024 | Varithena Administration Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunitha Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.